{"version":"1.0","type":"link","title":"Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers.","author_name":"Tendler S 외","author_url":"https://prs-insight.online/author/Tendler%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97346","thumbnail_width":1200,"thumbnail_height":630}